Overview

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Insulin will safely reduce glucose levels in patients with acute ST-elevation myocardial infarction and admission hyperglycemia.
Phase:
Phase 3
Details
Lead Sponsor:
Population Health Research Institute
Treatments:
Insulin
Insulin Glargine
Insulin glulisine
Insulin, Globin Zinc